Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas and Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. In addition, the company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. Further, its labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Stock data | 2023 | Change |
---|---|---|
Price | $0.02843 | N/A |
Market Cap | $2.39M | N/A |
Shares Outstanding | 83.93M | 13.15% |
Employees | 17.00 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $0 | N/A |
Earnings | $246.77K | N/A |
EPS | 0 | N/A |
Earnings Yield | 0 | N/A |